OTC · Biotechnology

Appili Therapeutics Inc (APLIF) Stock

$0.01 +0.00% OTC: APLIF Healthcare

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease.

Valuation

MetricValue
Price$0.01
Market Cap$1.46M
P/E Ratio-0.44
P/B Ratio-0.11
P/S Ratio7.61
EPS (TTM)$-0.03
52-Week High$0.03
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE26.47%
ROA-214.47%
ROCE33.15%
Gross Margin96.90%
Operating Margin—
Net Margin—
Debt/Equity-0.75
Current Ratio0.11

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.0M$0$1.0M$0$0
Operating Profit$-24.0M$-8.0M$-2.0M$0$-7.0M
Net Profit$-25.0M$-9.0M$-4.0M$-3.0M$-4.0M
EPS$-0.38$-0.08$-0.03$-0.02$-0.03
Op Margin-1698.1%-2326.9%-261.4%-190.0%-2675.7%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$18.0M$8.0M$1.0M$3.0M$2.0M
Total Liabilities$6.0M$12.0M$12.0M$16.0M$19.0M
Cash$11.0M$7.0M$0$1.0M$0
Borrowings$1.0M$5.0M$8.0M$12.0M$13.0M

Latest News

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program GlobeNewswire · Jul 3, 2026 Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results GlobeNewswire · Jun 26, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-11.0M$-19.0M$-2.0M$1.0M$-1.0M
Investing Cash Flow$0$5.0M$0$0$0
Financing Cash Flow$8.0M$0$0$0$0
Net Cash Flow$1.0M$-4.0M$-2.0M$1.0M$-1.0M
Free Cash Flow$-11.0M$-19.0M$-2.0M$1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-2.99
FCF Yield-68.68%
Quick Ratio0.11
Interest Coverage-4.49
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.06%
Institutions Held10.85%
Institutions Float Held10.85%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Appili Therapeutics Inc

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.

Appili Therapeutics Inc is headquartered in CA.

Appili Therapeutics Inc (APLIF) stock trades at $0.01 with a market capitalization of $1.46M. The stock is valued at a price-to-earnings (P/E) ratio of -0.44, price-to-book of -0.11, price-to-sales of 7.61. Over the past 52 weeks the stock has ranged between $0.01 and $0.03, and currently trades 66.7% below its 52-week high.

On profitability, Appili Therapeutics Inc generates a return on equity (ROE) of 26.47% — well above the market average, a sign of a high-quality business, return on capital employed of 33.15%.

Official website: www.appilitherapeutics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides